Bombay Hospital Journal ContentsHomeArchivesSearchBooksFeedback

ORIGINAL / RESEARCH

A COMPARATIVE STUDY OF HERBAL TREATMENT VERSUS MODERN MEDICAL TREATMENT FOR FISSURE-IN-ANO
Deepak G Langade, S Balakrishnan, Girish D Bakhshi, Sheetal S Sankhe, Swati B Lad, VY Deshpande, GB Daver

 
Introduction: Efficacy and safety of herbal treatment was compared with modern medicine treatment in patients of fissure-in-ano.
Methods: Fifty patients of anal fissure attending the surgery OPD randomly received the study (25) medication (Herbal ointment and Herbal oral powder) or control (25) medication (lignocaine jelly application and oral liquid paraffin) after obtaining written informed consent. Clinical evaluation done by proctoscopy and PR (per rectal) examination for constipation, pruritus, bleeding per rectal (PR), discharge and anal spasm for a period of 4 weeks. Pain was evaluated on Visual Analogue Scale (VAS). Effect on renal and hepatic functions was evaluated by laboratory investigations.
Results: Twenty three patients from study group and 21 from control group completed the study. Pain scores significantly reduced on days 7, 14 and 28 with both the treatments (p < 0.05) and the reduction was similar in both groups (p > 0.05). Improvement in constipation, bleeding and anal spasm was comparable in the two groups. Healing was better in the control group at the end of study. Hepatic and renal functions were unaltered in all patients.
Conclusion: Herbal ointment and Herbal powder provided significant symptomatic improvement in patients of fissure-in-ano which is comparable to the standard therapy.
 
INTRODUCTION

Anal fissure is a common problem that causes substantial morbidity in people who are otherwise healthy. The incidence of anal fissure is similar in men and women.1,2 Spasm of the anal sphincter has been noted in association with anal fissure,3,4 and for many years treatment has been focused on alleviating hypertonia of the sphincter. The most common treatment for chronic anal fissure has been lateral internal sphincterotomy which is simple and effective, but the fundamental drawback of surgery is its potential to cause minor but sometimes permanent alterations in the control of gas, mucus, and occasionally, stool.1-3,5-7 Pharmacological sphincterotomy with injection of botulinum toxin8 and application of nitroglycerin ointment, calcium channel blockers and phosphodiesterase inhibitors have been used to eliminate the need for surgery and avoid the risk of permanent injury to the internal anal sphincter, but have shown to be inconsistent in promoting healing of fissure.9-14

A reduction in the anal spasm by use of local anaesthetics or smooth muscle relaxants and preventing constipation with emollients allows the fissure to heal.

erbal ointment is a proprietory herbal preparation containing ingredients having anti-inflammatory15-19 anti-microbial,20 immuno-modulatory,21,22 emollient and analgesic activity.

Herbal powder is a proprietory herbal preparation having laxative action. It is useful as a demulcent in inflammatory19 and irritable affections.

Herbal ointment is advocated as an adjuvant therapy with Herbal powder in patients of ano-rectal disorders.

Hence, the present study was planned to study the efficacy of herbal ointment as local application along with herbal powder orally in comparison with local application of Lignocaine jelly along with liquid paraffin emulsion orally.

 
METHODS 
Aim
To compare the efficacy and safety of herbal treatment versus modern medicine treatment in patients of fissure-in-ano.

Study Population
A total of 50 patients attending the surgical outpatient department of the tertiary health care institute, who were diagnosed as fissure-in-ano were enrolled during April 2002 to August 2002 after obtaining informed written consent. Patients with haemorrhoids, diabetes, ischaemic heart disease (IHD), congestive cardiac failure (CCF), irritable bowel syndrome (IBS), chronic inflammatory bowel disease (CIBD), carcinoma colon, hepatic and renal disorders and those who had undergone anal surgical procedures in the past were excluded.

Study Design
This was a single blind, comparative, randomized study. The treating physician was unaware of the randomization code. The study protocol was approved by the Institutional Ethics Committee.

Interventions
All patients were screened by clinical evaluation, proctoscopy and laboratory investigations. Eligible patients were randomly assigned as per the computer generated randomization chart to one of the following two groups.

Study group
HERBAL OINTMENT contains Yashtimadhu (Glycyrrhiza glabra) 3 gms which has anti-inflammatory and immunomodulatory activity, Haridra (Curcuma longa) 2 gms having anti-inflammatory, antioxidant and immunomodulatory
activity, Lajjawati (Mimosa pudica) 2 gms having antimicrobial activity, Rudhra sal (Symplocus racemosa) 2 gms, Babul sal (Acacia arabica) 3 gms having antimicrobial and hypoglycemic activity, Peepal sal (Ficus religiosa) 2 gms having antibacterial activity, Wat sal (Ficus bengalensis) 2 gms having antibacterial, antioxidant and antidiabetic activity, Udumber sal (Ficus glomerata) 2 gms having hypolipidaemic activity, Til oil (Sessamum indicum) 15 ml having antiproliferative and antioxidant activity, Madhu (Honey) 10 ml having wound healing properties, Chandan oil (Santalum album) 0.1 ml and Ointment base upto 100 gms.

HERBAL POWDER contains Isapgol (Plantago Isapgula), Sannay (Cassia angustifolia), Madhurika (Foeniculum vulgare) and Yashtimadhu (Glycyrrhiza glabra) which are having laxative activities.
Study group received Herbal ointment applied twice daily locally and Herbal powder 10 grams daily orally.

Control group
LAXATIVE EMULSION contains (each 15 ml) Liquid paraffin 3.75 ml and Milk of magnesia 11.25 ml.
LIGNOCAINE JELLY 2 % is a local anaesthetic.
Control group received lignocaine jelly 2% applied twice daily locally and laxative emulsion oral administration 10 ml daily.
Follow-Up and Assessment
Patients were followed up on days 7, 14 and 28 or in event of any adverse effect related to the medication, aggravation of symptoms or excess bleeding.

Pain assessment was done on a 0-100 VAS. Assessment was done by clinical examination, proctoscopy and history at enrolment and on days 7, 14 and 28 for bleeding, ulcer healing, pruritus, anal spasm and constipation.
Statistical Analysis
Symptomatic improvement was defined as persistence of fissure without symptoms. Ulcer healing in the two groups was analyzed by Chi-square test for statistical significance. Improvement in pain scores was analyzed by ‘t’-test for significance between the two groups.
 
RESULTS
Forty four patients completed the study (23 study and 21 control) and 6 patients were lost to follow up (4 study and 2 control). Two groups were similar with regards to demographic data and symptom scores at enrolment (Table 1).





Pain scores improved significantly in both the treatment groups on days 7, 14 and 28, the difference being statistically significant (p < 0.05, paired ‘t’-test) (Fig. 1). Reduction in pain score from baseline values on days 7, 14 and 28 was found to be similar in the two treatment groups (Table 2), there being no statistically significant difference between the two treatment groups (p > 0.05, unpaired ‘t’-test). 17 (73.91%) patients in study group and 14 (66.66%) patients in control group reported adequate pain control (p > 0.05 by Chi-Square test).

22 (95.62%) patients in the study and 19 (90.47%) in the control group reported constipation on enrolment. At the end of the study, only 1 (4.34%) patient in study and 3 (14.28%) in control had constipation. The incidence of constipation reduced in both groups (Fig. 2).

4 (17.39%) patients in study and 2 (9.52%) in control group had pruritus at enrolment whereas 3 (14.28%) patients from the study and 2 (9.52%) from the control reported anal pruritus after starting the study treatment.

On enrolment 16 (69.56%) patients in study and 17 (80.95%) in control group had severe anal spasm. Number of patients having anal spasm reduced to 4 (17.39%) in the study group and no patient had anal spasm in the control group at the end of the study period.

5 (21.73%) patients in the study group and 10 (47.61 %) in the control group had healed fissures at the end of the study, the difference between the two treatment groups being statistically significant (p < 0.05 Chi-Square test).

Symptomatic improvement was seen in 13 (56.52%) patients in study group and 10 (47.61%) patients in control group.

All the laboratory parameters remained unaltered during the study period in both the treatment groups.

Nine patients in study group and 8 in the control group had per rectal bleeding on enrolment. On day 28, there was no bleeding in 7 out of 8 patients in the study group; one patient reported bleeding during treatment period, whereas in the control group anal bleeding stopped in 5 out of 8 patients and one patient had increased bleeding.

One patient in each of the two groups reported burning sensation in the anal region after starting the treatment. One patient in the study group had prolapsed piles and was referred for surgery on day 14. No other complications or side effects were reported in any of the patients.


 
DISCUSSION

Anal dilatation and sphincterotomy under general or local anaesthesia is the preferred management of anal fissure, but surgery is associated with a number of complications, most common being incontinence, which in 8 to 30 percent of patients is permanent.12,23 Recently, chronic fissures have been successfully treated with topical nitroglycerin ointment, injection of botulinum toxin, calcium channel blockers and phosphodiesterase inhibitors.9-14,24

Our study compared the use of lignocaine jelly local application along with use of a laxative versus herbal study medication which consisted of Herbal ointment for local application and Herbal powder orally as a laxative. Present study shows significant improvement in symptoms of anal fissure with the study treatment and this improvement is comparable to the control treatment.

Herbal ointment contains various ingredients which have shown to have anti-inflammatory15-19 anti-microbial,20 immunomodulatory,21,22 emollient and analgesic activity. Anal fissure is associated with local inflammation, which leads to pain and anal spasm. Extracts of Curcumin, Glycirrhaza and Ficus species have potent anti-inflammatory activity16,18,19 which helps in reducing the inflammation thus reducing anal spasm. Reducing anal spasm has shown to improve the healing rate in previous studies.9,10,24 Honey is known to have emollient and wound healing properties and has shown to promote healing of infected venous leg ulcers.25

Herbal powder contains Isapgol (Plantago Isapgula) as a main ingredient which is a potent laxative, which prevents straining at stools thus reducing pain and anal spasm.

Reduction in anal spasm was better in the control group in the present study, which may be attributed to the local anaesthetic in the control group. Ulcer healing was found to be better in the control group.

In summary, we found Herbal ointment and Herbal powder to provide adequate symptomatic relief, which was comparable to the standard pharmacological therapy for anal fissure. Further large-scale multi-centric studies should be conducted to evaluate the efficacy and safety of these preparations in patients of anal fissure.

 
ACKNOWLEDGEMENT
We kindly acknowledge VAIPANI HERBAL, Nagpur for supplying the study medication. We also acknowledge the efforts of Mr. Dashrathe, In-charge, drug store for his assistance in the work.
 
REFERENCES
1.
Anal fissure. In: Corman ML. Colon and rectal surgery. 4th ed. Philadelphia: Lippincott-Raven, 1998:206-23.
2.
Lund JN, Scholefield JH. Aetiology and treatment of anal fissure. Br J Surg 1996; 83:1335-1344.
3.
Farouk R, Duthie GS, MacGregor AB, Bartolo DC. Sustained internal anal sphincter hypertonia in patients with chronic anal fissure. Dis Colon Rectum 1994; 37: 424-429.
4.
Eisenhammer S. Surgical correction of chronic internal anal (sphincteric) contracture. S Afr Med J 1951; 25: 486-489.
5.
Khubchandani IT, Reed JF. Sequelae of internal sphincterotomy for chronic fissure in ano. Br J Surg 1989; 76: 431-434.
6.
Hsu TC, MacKeigan JM. Surgical treatment of chronic anal fissure: a retrospective study of 1753 cases. Dis Colon Rectum 1984; 27: 475-478.
7.
Rosen L, Abel ME, Gordon PH, et al. Practice parameters for the management of anal fissure. Dis Colon Rectum 1992; 35: 206-208.
8.
Jost WH, Schimrigk K. Therapy of anal fissure using botulin toxin. Dis Colon Rectum 1994; 37:1321-1324.
9.
Gui D, Cassetta E, Anastasio G, Bentivoglio AR, Maria G, Albanese A. Botulinum toxin for chronic anal fissure. Lancet 1994; 344: 1127-1128.
10.
Loder PB, Kamm MA, Nicholls RJ, Phillips RK. ‘Reversible chemical sphincterotomy’ by local application of glyceryl trinitrate. Br J Surg 1994; 81:1386-1389.
11.
Gorfine SR. Topical nitroglycerin therapy for anal fissures and ulcers. N Engl J Med 1995; 333: 1156-1157.
12.
Lund JN, Armitage NC, Scholefield JH. Use of glyceryl trinitrate ointment in the treatment of anal fissure. Br J Surg 1996; 83: 776-777.
13.
Phillips R. Pharmacologic treatment of anal fissure with botoxin, diltiazem, or bethanechol. J Gastrointest Surg 2002; 6 (3): 281-3.
14.
Jones OM, Brading AF, McC Mortensen NJ. Phosphodiesterase inhibitors cause relaxation of the internal anal sphincter in vitro. Dis Colon Rectum 2002; 45 (40):530-6.
15.
Das KC, Das CK. Curcumin (diferuloylmethane), a singlet oxygen ((1)O(2)) quencher. Biochem Biophys Res Commun 2002; 295 (1):62-6.
16.
Mandal SC, Maity TK, Das J, Saba BP, Pal M. Anti-inflammatory evaluation of Ficus racemosa Linn. leaf extract. J Ethnopharmacol 2000; 72 (1-2) : 87-92.
17.
Pal S, Choudhuri T, Chattopadhyay S, Bhattacharya A, Datta GK, Das T, Sa G. Mechanisms of curcumin-induced apoptosis of Ehrlich’s ascites carcinoma cells. Biochem Biophys Res Commun 2001; 288(3):658-65.
18.
Sidhu GS, Mani H, Gaddipati JP, Singh AK, Seth P, Banaudha KK, Patnaik GK, Maheshwari RK. Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice. Wound Repair Regen 1999; 7 (5) : 362-74.
19.
Francischetti IM, Monteiro RQ, Guimaraes JA, Francischetti B. Erratum in: Biochem Biophys Res Commun 1997; 237 (1) : 203. Francischetti B [corrected to Francischetti IM] Identification of glycyrrhizin as a thrombin inhibitor. Biochem Biophys Res Commun 1997; 235 (1) : 259-63.
20.
Almas K.The antimicrobial effects of seven different types of Asian chewing sticks. Odontostomatol Trop 2001; 24 (96) : 17-20.
21.
Antony S, Kuttan R, Kuttan G. Immunomodulatory activity of curcumin. Immunol Invest 1999; 28 (5-6): 291-303.
22.
Nose M, Terawaki K, Oguri K, Ogihara Y, Yoshimatsu K, Shimomura K. Activation of macrophages by crude polysaccharide fractions obtained from shoots of Glycyrrhiza glabra and hairy roots of Glycyrrhiza uralensis in vitro. Biol Pharm Bull 1998; 21 (10) : 1110-2.
23.
Pernikoff BJ, Eisenstat TE, Rubin RJ, Oliver GC, Salvati EP. Reappraisal of partial lateral internal sphincterotomy. Dis Colon Rectum 1994; 37 : 1291-1295.
24.
Brisinda G, Maria G, Bentivoglio AR, Cassetta E, Gui D, Albanese A. A Comparison of Injections of Botulinum Toxin and Topical Nitroglycerin Ointment for the Treatment of Chronic Anal Fissure. N Engl J Med 1999; 341: 65-69.
25.
Alcaraz A, Kelly J. Treatment of an infected venous leg ulcer with honey dressings. Br J Nurs 2002; 11(13):859-66.
 

To Section TOC
Sponsor-Dr.Reddy's Lab